BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 12941882)

  • 1. Productive lytic replication of a recombinant Kaposi's sarcoma-associated herpesvirus in efficient primary infection of primary human endothelial cells.
    Gao SJ; Deng JH; Zhou FC
    J Virol; 2003 Sep; 77(18):9738-49. PubMed ID: 12941882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spindle cell conversion by Kaposi's sarcoma-associated herpesvirus: formation of colonies and plaques with mixed lytic and latent gene expression in infected primary dermal microvascular endothelial cell cultures.
    Ciufo DM; Cannon JS; Poole LJ; Wu FY; Murray P; Ambinder RF; Hayward GS
    J Virol; 2001 Jun; 75(12):5614-26. PubMed ID: 11356969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. De novo infection and serial transmission of Kaposi's sarcoma-associated herpesvirus in cultured endothelial cells.
    Lagunoff M; Bechtel J; Venetsanakos E; Roy AM; Abbey N; Herndier B; McMahon M; Ganem D
    J Virol; 2002 Mar; 76(5):2440-8. PubMed ID: 11836422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficient infection by a recombinant Kaposi's sarcoma-associated herpesvirus cloned in a bacterial artificial chromosome: application for genetic analysis.
    Zhou FC; Zhang YJ; Deng JH; Wang XP; Pan HY; Hettler E; Gao SJ
    J Virol; 2002 Jun; 76(12):6185-96. PubMed ID: 12021352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycolysis, Glutaminolysis, and Fatty Acid Synthesis Are Required for Distinct Stages of Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication.
    Sanchez EL; Pulliam TH; Dimaio TA; Thalhofer AB; Delgado T; Lagunoff M
    J Virol; 2017 May; 91(10):. PubMed ID: 28275189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Full-Length Isoforms of Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Accumulate in the Cytoplasm of Cells Undergoing the Lytic Cycle of Replication.
    Garrigues HJ; Howard K; Barcy S; Ikoma M; Moses AV; Deutsch GH; Wu D; Ueda K; Rose TM
    J Virol; 2017 Dec; 91(24):. PubMed ID: 28978712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of Kaposi's sarcoma-associated herpesvirus infection and replication by MEK/ERK, JNK, and p38 multiple mitogen-activated protein kinase pathways during primary infection.
    Pan H; Xie J; Ye F; Gao SJ
    J Virol; 2006 Jun; 80(11):5371-82. PubMed ID: 16699017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptome analysis of Kaposi's sarcoma-associated herpesvirus during de novo primary infection of human B and endothelial cells.
    Purushothaman P; Thakker S; Verma SC
    J Virol; 2015 Mar; 89(6):3093-111. PubMed ID: 25552714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) lytic replication by human cytomegalovirus.
    Vieira J; O'Hearn P; Kimball L; Chandran B; Corey L
    J Virol; 2001 Feb; 75(3):1378-86. PubMed ID: 11152511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening of the Human Kinome Identifies MSK1/2-CREB1 as an Essential Pathway Mediating Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication during Primary Infection.
    Cheng F; Sawant TV; Lan K; Lu C; Jung JU; Gao SJ
    J Virol; 2015 Sep; 89(18):9262-80. PubMed ID: 26109721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transformation of primary human endothelial cells by Kaposi's sarcoma-associated herpesvirus.
    Flore O; Rafii S; Ely S; O'Leary JJ; Hyjek EM; Cesarman E
    Nature; 1998 Aug; 394(6693):588-92. PubMed ID: 9707121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Replication Machinery of Kaposi's Sarcoma-associated Herpesvirus and Drug Discovery Research].
    Watanabe T; Fujimuro M
    Yakugaku Zasshi; 2019; 139(1):69-73. PubMed ID: 30606932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Kaposi's sarcoma-associated herpesvirus (KSHV) non-structural membrane protein K15 is required for viral lytic replication and may represent a therapeutic target.
    Abere B; Mamo TM; Hartmann S; Samarina N; Hage E; Rückert J; Hotop SK; Büsche G; Schulz TF
    PLoS Pathog; 2017 Sep; 13(9):e1006639. PubMed ID: 28938025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FoxO1 Suppresses Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication and Controls Viral Latency.
    Gao R; Li T; Tan B; Ramos da Silva S; Jung JU; Feng P; Gao SJ
    J Virol; 2019 Feb; 93(3):. PubMed ID: 30404794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reactivation of Kaposi's sarcoma-associated herpesvirus from latency requires MEK/ERK, JNK and p38 multiple mitogen-activated protein kinase pathways.
    Xie J; Ajibade AO; Ye F; Kuhne K; Gao SJ
    Virology; 2008 Feb; 371(1):139-54. PubMed ID: 17964626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of Kaposi's Sarcoma-Associated Herpesvirus Infection and Replication by 5'-AMP-Activated Protein Kinase.
    Cheng F; He M; Jung JU; Lu C; Gao SJ
    J Virol; 2016 Jul; 90(14):6515-6525. PubMed ID: 27147746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kaposi's Sarcoma-Associated Herpesvirus Nonstructural Membrane Protein pK15 Recruits the Class II Phosphatidylinositol 3-Kinase PI3K-C2α To Activate Productive Viral Replication.
    Abere B; Samarina N; Gramolelli S; Rückert J; Gerold G; Pich A; Schulz TF
    J Virol; 2018 Sep; 92(17):. PubMed ID: 29950425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of the red fluorescent protein as a marker of Kaposi's sarcoma-associated herpesvirus lytic gene expression.
    Vieira J; O'Hearn PM
    Virology; 2004 Aug; 325(2):225-40. PubMed ID: 15246263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabinoid modulation of Kaposi's sarcoma-associated herpesvirus infection and transformation.
    Zhang X; Wang JF; Kunos G; Groopman JE
    Cancer Res; 2007 Aug; 67(15):7230-7. PubMed ID: 17671191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term-infected telomerase-immortalized endothelial cells: a model for Kaposi's sarcoma-associated herpesvirus latency in vitro and in vivo.
    An FQ; Folarin HM; Compitello N; Roth J; Gerson SL; McCrae KR; Fakhari FD; Dittmer DP; Renne R
    J Virol; 2006 May; 80(10):4833-46. PubMed ID: 16641275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.